FEATURED COMPANIES
- Arthrex Inc.
- Isto Biologics
- Medtronic Plc
- Orthofix Medical Inc.
- Stryker Corporation
- Terumo Corporation
The global bone growth stimulators market was valued at $1,242 million in 2018, and is estimated to reach at $1,869 million by 2026, registering a CAGR of 5.2% from 2019 to 2026.
Bone growth stimulators are used for bone growth, which also aid in broken bone healing process. Bone growth stimulators help in production of new bone cells and work in case of all fractures. In addition, it is used for healing of long leg bones such as tibia and in surgical procedures such as spinal fusions, which are difficult to heal. Bone growth stimulators include bone growth stimulation devices, bone morphogenetic proteins, and platelet-rich plasma.
a rise in the number of trauma and accident cases, increase in The prevalence of arthritis, surge in inclination of patients toward minimally invasive & non-invasive surgical treatments, rise in geriatric population, and rapid demand and adoption of platelet-rich plasma and bone morphogenetic proteins are some factors that fuel the growth of the bone growth stimulators market. In addition, rise in cases of diabetes and other medical conditions such as obesity, vascular disease, and renal disorders are also expected to drive the market during the forecast period. Moreover, bone growth stimulation products offer more benefits compared to traditional surgical therapies such as cost-effective and safe alternative mode to treat orthopedic diseases and bone fracture treatment. However, stringent approval process and limited medical reimbursement policies for bone stimulation products are expected to hinder the growth of the market.
The bone growth stimulators market is segmented into product, application, distribution channel, and region. By product, it is categorized into bone growth stimulation devices, bone morphogenetic proteins, and platelet-rich plasma. Depending on application, it is classified into spinal fusion surgeries, delayed union & nonunion bone fractures, oral & maxillofacial surgeries, and others. By distribution channel, it is divided into hospitals & clinics, home care, and others. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
KEY BENEFITS FOR STAKEHOLDERS
KEY MARKET SEGMENTS
By Product
By Application
By Distribution Channel
By Region
LIST OF KEY PLAYERS PROFILED IN THE REPORT
LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request.)
Bone growth stimulators are used for bone growth, which also aid in broken bone healing process. Bone growth stimulators help in production of new bone cells and work in case of all fractures. In addition, it is used for healing of long leg bones such as tibia and in surgical procedures such as spinal fusions, which are difficult to heal. Bone growth stimulators include bone growth stimulation devices, bone morphogenetic proteins, and platelet-rich plasma.
a rise in the number of trauma and accident cases, increase in The prevalence of arthritis, surge in inclination of patients toward minimally invasive & non-invasive surgical treatments, rise in geriatric population, and rapid demand and adoption of platelet-rich plasma and bone morphogenetic proteins are some factors that fuel the growth of the bone growth stimulators market. In addition, rise in cases of diabetes and other medical conditions such as obesity, vascular disease, and renal disorders are also expected to drive the market during the forecast period. Moreover, bone growth stimulation products offer more benefits compared to traditional surgical therapies such as cost-effective and safe alternative mode to treat orthopedic diseases and bone fracture treatment. However, stringent approval process and limited medical reimbursement policies for bone stimulation products are expected to hinder the growth of the market.
The bone growth stimulators market is segmented into product, application, distribution channel, and region. By product, it is categorized into bone growth stimulation devices, bone morphogenetic proteins, and platelet-rich plasma. Depending on application, it is classified into spinal fusion surgeries, delayed union & nonunion bone fractures, oral & maxillofacial surgeries, and others. By distribution channel, it is divided into hospitals & clinics, home care, and others. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
KEY BENEFITS FOR STAKEHOLDERS
- The study provides an in-depth analysis of the global bone growth stimulators market along with the current trends and future estimations to elucidate the imminent investment pockets.
- A comprehensive analysis of the factors that drive and restrict the market growth is provided in the report.
- Comprehensive quantitative analysis of the industry from 2018 to 2026 is provided to enable the stakeholders to capitalize on prevailing market opportunities.
- Extensive analysis of the key segments of the industry helps to understand the application and products of bone growth stimulators used across the globe.
- Key market players and their strategies have been analyzed to understand the competitive outlook of the market.
KEY MARKET SEGMENTS
By Product
- Bone Growth Stimulation Devices
- Bone Morphogenetic Proteins
- Platelet-Rich Plasma
By Application
- Spinal Fusion Surgeries
- Delayed Union & Nonunion Bone Fractures
- Oral & Maxillofacial Surgeries
- Others
By Distribution Channel
- Hospitals & Clinics
- Home Care
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
LIST OF KEY PLAYERS PROFILED IN THE REPORT
- Arthrex, Inc.
- Essex Woodlands Healthcare Partners (Bioventus LLC)
- Colfax Corporation (DJO Global, Inc)
- Isto Biologics
- Johnson & Johnson (Depuy Synthes)
- Medtronic PLC
- Orthofix Medical Inc.
- Stryker Corporation
- Terumo Corporation
- Zimmer Biomet Holdings, Inc.
LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request.)
- ITO Physiotherapy & Rehabilitation
- Orchid Medical
- Ossatec Benelux Ltd.
Frequently Asked Questions about the Global Bone Growth Stimulators Market
What is the estimated value of the Global Bone Growth Stimulators Market?
What is the growth rate of the Global Bone Growth Stimulators Market?
What is the forecasted size of the Global Bone Growth Stimulators Market?
Who are the key companies in the Global Bone Growth Stimulators Market?
Note: Product cover images may vary from those shown
FEATURED COMPANIES
- Arthrex Inc.
- Isto Biologics
- Medtronic Plc
- Orthofix Medical Inc.
- Stryker Corporation
- Terumo Corporation
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET OVERVIEW
CHAPTER 4: BONE GROWTH STIMULATORS TREATMENT MARKET, BY PRODUCT
CHAPTER 5: BONE GROWTH STIMULATORS TREATMENT MARKET, BY APPLICATION
CHAPTER 6: BONE GROWTH STIMULATORS TREATMENT MARKET, BY DISTRIBUTION CHANNEL
CHAPTER 7: BONE GROWTH STIMULATORS MARKET, BY REGION
CHAPTER 8: COMPANY PROFILES
Note: Product cover images may vary from those shown
FEATURED COMPANIES
- Arthrex Inc.
- Isto Biologics
- Medtronic Plc
- Orthofix Medical Inc.
- Stryker Corporation
- Terumo Corporation
According to this report titled, 'Bone Growth Stimulators Market by Product, Application, and Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2019-2026' the global bone growth stimulators market size was valued at $1,242 million in 2018, and is projected to reach $1,869 million by 2026, growing at a CAGR of 5.2% from 2019 to 2026.
Bone growth stimulators are used to aid natural healing process of bones. They are also known as osteogenesis stimulators, which offer pain-free ultrasound or electrical stimulation. Bone growth stimulators work by releasing either a low-level pulsed electromagnetic field or pulsed ultrasonic energy. The cost incurred in the application of minimally invasive bone growth stimulators is less as compared to traditional bone surgical treatment methods. There are different bone growth stimulator products available in the market, which include bone growth stimulation devices, bone morphogenetic proteins, and platelet-rich plasma.
The bone growth stimulators market is expected to experience a significant growth during the forecast period, owing to rise in incidence of fractured and accidents, rise in geriatric population, increase in inclination of patients toward minimally invasive & non-invasive surgical treatments, rise in demand for platelet-rich plasma and bone morphogenetic proteins, availability of cost effective bone growth stimulation devices, and surge in patient awareness toward bone growth stimulators. In addition, increase in The prevalence of arthritis, diabetes, and other medical conditions such as obesity, vascular disease, and renal disorders; and procedural benefits provided by bone growth stimulation devices in bone fracture treatment and orthopedic diseases boost the market growth. However, stringent approval process and limited medical reimbursement policies for bone stimulation products are expected to hinder the growth of the market.
By product, the bone growth stimulation devices is the major revenue contributor, and is projected to grow significantly during the forecast period The key factors that drive the market growth are rise in demand for bone growth stimulation devices, rise in geriatric population, increase in incidence of spinal deformities, technological advancements, development in bone growth stimulation devices, and a rise in the number of bone and joint problems.
On the basis of application, the spinal fusion surgeries segment accounted for the majority of the market share in 2018, owing to rise in incidences of spinal disorders, adoption rate of minimally invasive spinal surgeries, rise in technological advancements in spinal surgery, increase in incidence of obesity & degenerative spinal conditions, and an increase in patient preference toward spinal fusion surgery procedures across the globe.
According to Onkar Sumant, Manager, Healthcare, “growth of the bone growth stimulators market is attributed to increase in demand for bone growth stimulator devices. Furthermore, a rise in the adoption of minimally invasive & non-invasive surgical treatments and surge in geriatric population across the globe are other factors that contribute to the growth of the market.”
KEY FINDINGS OF THE STUDY
North America accounted for approximately 53.22% of the global bone growth stimulators market share in 2018 and is expected to remain dominant throughout the forecast period. This was attributed to the higher adoption of bone growth stimulator products, large presence of medical device companies, well developed healthcare infrastructure, and wide availability of bone growth stimulators drugs. On the other side, Asia-Pacific is expected to experience the highest growth rate during the forecast period, majorly due to improvements in healthcare infrastructure, a rise in the number of hospitals equipped with advanced medical facilities, developing R&D sector, rise in healthcare reforms, and technological advancements in the field of healthcare.
Bone growth stimulators are used to aid natural healing process of bones. They are also known as osteogenesis stimulators, which offer pain-free ultrasound or electrical stimulation. Bone growth stimulators work by releasing either a low-level pulsed electromagnetic field or pulsed ultrasonic energy. The cost incurred in the application of minimally invasive bone growth stimulators is less as compared to traditional bone surgical treatment methods. There are different bone growth stimulator products available in the market, which include bone growth stimulation devices, bone morphogenetic proteins, and platelet-rich plasma.
The bone growth stimulators market is expected to experience a significant growth during the forecast period, owing to rise in incidence of fractured and accidents, rise in geriatric population, increase in inclination of patients toward minimally invasive & non-invasive surgical treatments, rise in demand for platelet-rich plasma and bone morphogenetic proteins, availability of cost effective bone growth stimulation devices, and surge in patient awareness toward bone growth stimulators. In addition, increase in The prevalence of arthritis, diabetes, and other medical conditions such as obesity, vascular disease, and renal disorders; and procedural benefits provided by bone growth stimulation devices in bone fracture treatment and orthopedic diseases boost the market growth. However, stringent approval process and limited medical reimbursement policies for bone stimulation products are expected to hinder the growth of the market.
By product, the bone growth stimulation devices is the major revenue contributor, and is projected to grow significantly during the forecast period The key factors that drive the market growth are rise in demand for bone growth stimulation devices, rise in geriatric population, increase in incidence of spinal deformities, technological advancements, development in bone growth stimulation devices, and a rise in the number of bone and joint problems.
On the basis of application, the spinal fusion surgeries segment accounted for the majority of the market share in 2018, owing to rise in incidences of spinal disorders, adoption rate of minimally invasive spinal surgeries, rise in technological advancements in spinal surgery, increase in incidence of obesity & degenerative spinal conditions, and an increase in patient preference toward spinal fusion surgery procedures across the globe.
According to Onkar Sumant, Manager, Healthcare, “growth of the bone growth stimulators market is attributed to increase in demand for bone growth stimulator devices. Furthermore, a rise in the adoption of minimally invasive & non-invasive surgical treatments and surge in geriatric population across the globe are other factors that contribute to the growth of the market.”
KEY FINDINGS OF THE STUDY
- On the basis of product, the bone growth stimulation devices segment held more than 51.21% share in the global market in 2018.
- On the basis of application, the spinal fusion surgeries segment held largest market share in 2018, and is expected to remain dominant throughout the forecast period.
- According to distribution channel, the hospitals & clinics segment exhibits fastest growth and is expected to grow at a CAGR of 5.6% from 2019 to 2026.
- Region wise, Asia-Pacific is expected to experience growth at the highest rate, registering a CAGR of 7.0% during the forecast period.
North America accounted for approximately 53.22% of the global bone growth stimulators market share in 2018 and is expected to remain dominant throughout the forecast period. This was attributed to the higher adoption of bone growth stimulator products, large presence of medical device companies, well developed healthcare infrastructure, and wide availability of bone growth stimulators drugs. On the other side, Asia-Pacific is expected to experience the highest growth rate during the forecast period, majorly due to improvements in healthcare infrastructure, a rise in the number of hospitals equipped with advanced medical facilities, developing R&D sector, rise in healthcare reforms, and technological advancements in the field of healthcare.
Note: Product cover images may vary from those shown
- Arthrex Inc.
- Essex Woodlands Healthcare Partners (Bioventus LLC)
- Colfax Corporation (DJO Global Inc.)
- Isto Biologics
- Johnson & Johnson (Depuy Synthes)
- Medtronic Plc
- Orthofix Medical Inc.
- Stryker Corporation
- Terumo Corporation
- Zimmer Biomet Holdings Inc
Note: Product cover images may vary from those shown
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
